Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M48,756Revenue $M6,300Net Margin (%)15.6Z-Score9.2
Enterprise Value $M47,202EPS $3.3Operating Margin %28.7F-Score7
P/E(ttm))38.5Cash Flow Per Share $4.6Pre-tax Margin (%)27.5Higher ROA y-yY
Price/Book7.110-y EBITDA Growth Rate %15.5Quick Ratio3.8Cash flow > EarningsY
Price/Sales7.25-y EBITDA Growth Rate %27.6Current Ratio4.1Lower Leverage y-yY
Price/Cash Flow20.1y-y EBITDA Growth Rate %10.9ROA % (ttm)9.3Higher Current Ratio y-yN
Dividend Yield %0.1Insider Buy (3m)0ROE % (ttm)15.2Less Shares Outstanding y-yN
Payout Ratio %5.0Shares Outstanding M298ROI % (ttm)12.0Gross Margin Increase y-yY

Gurus Latest Trades with AGN

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AGNRichard Perry 2014-06-30 Buy 7.8%$116.63 - $173.95
($155.63)
$ 164.386%New holding, 1667625 sh.1,667,625
AGNJohn Paulson 2014-06-30 Buy 4.1%$116.63 - $173.95
($155.63)
$ 164.386%New holding, 5602000 sh.5,602,000
AGNJean-Marie Eveillard 2014-06-30 Buy 0.01%$116.63 - $173.95
($155.63)
$ 164.386%New holding, 30000 sh.30,000
AGNRay Dalio 2014-06-30 Sold Out -0.02%$116.63 - $173.95
($155.63)
$ 164.386%Sold Out0
AGNGeorge Soros 2014-03-31 Sold Out -0.09%$110.28 - $131.43
($121.38)
$ 164.3835%Sold Out0
AGNJoel Greenblatt 2014-03-31 Reduce-0.04%$110.28 - $131.43
($121.38)
$ 164.3835%Reduce -46%18,843
AGNRay Dalio 2014-03-31 Reduce-0.02%$110.28 - $131.43
($121.38)
$ 164.3835%Reduce -54.57%18,499
AGNFrank Sands 2013-12-31 Sold Out -1.9%$88.48 - $110.85
($95.35)
$ 164.3872%Sold Out0
AGNRay Dalio 2013-12-31 Reduce-0.14%$88.48 - $110.85
($95.35)
$ 164.3872%Reduce -81.99%40,719
AGNJoel Greenblatt 2013-12-31 Reduce-0.09%$88.48 - $110.85
($95.35)
$ 164.3872%Reduce -45.01%34,897
AGNJoel Greenblatt 2013-09-30 Add0.1%$84.24 - $92.63
($89.85)
$ 164.3883%Add 113.74%63,459
AGNGeorge Soros 2013-09-30 Buy 0.07%$84.24 - $92.63
($89.85)
$ 164.3883%New holding, 75000 sh.75,000
AGNFrank Sands 2013-09-30 Reduce-0.61%$84.24 - $92.63
($89.85)
$ 164.3883%Reduce -22.67%7,422,715
AGNRay Dalio 2013-06-30 Add0.17%$81.99 - $116.17
($103.71)
$ 164.3858%Add 2759.74%249,341
AGNJoel Greenblatt 2013-06-30 Add0.1%$81.99 - $116.17
($103.71)
$ 164.3858%Add 722.89%29,690
AGNFrank Sands 2013-06-30 Reduce-1.27%$81.99 - $116.17
($103.71)
$ 164.3858%Reduce -24.86%9,598,964
AGNFrank Sands 2013-03-31 Add0.35%$91.73 - $111.89
($106.54)
$ 164.3854%Add 7.38%12,774,895
AGNRay Dalio 2013-03-31 Reduce-0.12%$91.73 - $111.89
($106.54)
$ 164.3854%Reduce -93.77%8,719
AGNJoel Greenblatt 2013-03-31 Reduce-0.08%$91.73 - $111.89
($106.54)
$ 164.3854%Reduce -81.38%3,608
AGNFrank Sands 2012-12-31 Add0.72%$87.95 - $95.26
($91.85)
$ 164.3879%Add 19.46%11,896,641
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AGN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
AGN John Paulson 2014-06-305,602,0001.884.1New Buy
AGN Jean-Marie Eveillard 2014-06-3030,0000.010.01New Buy
AGN Richard Perry 2014-06-301,667,6250.567.8New Buy
AGN Mario Gabelli 2014-06-30131,1980.040.12+3.37%
AGN Dodge & Cox 2014-06-303,56400
AGN Joel Greenblatt 2014-06-3016,2810.010.03-13.6%
AGN Ray Dalio 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


AGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sherman Scott DExecutive Vice President, HR 2014-04-22Sell14,500$155.825.29view
INGRAM DOUGLAS SPresident 2014-02-21Sell1$125.730.52view
LAVIGNE LOUIS J JRDirector 2014-02-21Sell5,400$125.7930.42view
HUDSON DAWN EDirector 2014-02-19Sell4,200$126.3529.85view
Diradoorian Raymond HEVPGlobal Technical Operations 2014-02-19Sell23,000$126.6629.53view
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFO 2014-02-19Sell38,900$126.3929.8view
Sherman Scott DExecutive Vice President, HR 2014-02-18Sell5,001$125.7430.48view
INGRAM DOUGLAS SPresident 2014-02-14Sell84,000$124.431.88view
PYOTT DAVID E IChairman of the Board and CEO 2014-02-12Sell252,000$123.1233.25view
BARLOW JAMES FSR. VP, Corp. Controller (PAO) 2014-02-12Sell23,875$123.5232.82view

Press Releases about AGN :

Quarterly/Annual Reports about AGN:

News about AGN:

Articles On GuruFocus.com
George Soros Reveals His Largest Stake Jul 23 2014 
Bill Ackman Sits Down With Bloomberg - Allergan Is Not Being Raided In Valeant Deal Apr 25 2014 
Bill Ackman and Valeant Pharmaceuticals Team Up to Take Over Pharmaceutical Company Allergen Apr 23 2014 
Bill Ackman Presentation - Perspective from Allergan's Largest Shareholder Apr 23 2014 
Forest Laboratories Is an Option for Wealthy Investors Who Could Afford to Pay a High Premium Apr 23 2014 
Abbott Capturing Incremental Market Share Mar 18 2014 
Weekly CEO Sells Highlight: Cardinal Health, Envision Healthcare Holdings, Tableau Software and Alle Feb 16 2014 
Stock with High Forward Rate of Return, Donald Yacktman’s Measure Dec 26 2013 
Insiders Are Buying Ophthotech Oct 08 2013 
Sands Capital Management Update, Sells AAPL, Cuts GOOG and Others Sep 01 2013 


More From Other Websites
Valeant to deliver required requests Friday for Allergan meeting: report Aug 22 2014
How Will Allergan (AGN) Stock Respond To Special Shareholders Meeting Request By Valeant (VRX),... Aug 22 2014
Valeant, Ackman to submit Allergan special meeting request-CNBC Aug 22 2014
[video] Valeant's special meeting Aug 22 2014
ALLERGAN INC Files SEC form 8-K, Other Events Aug 22 2014
Why Allergan (AGN) Stock Is Lower Today Aug 22 2014
Allergan loses battle to make shareholder vote moot on Valeant bid Aug 21 2014
U.S. court denies Allergan bid to speed insider trading suit Aug 21 2014
Federal court denies Allergan bid to speed insider trading suit Aug 21 2014
Botox Maker Allergan’s Suit Against Valeant Won’t Delay Special Meeting Aug 21 2014
S&P 500 Marks New High As Indexes Hold Gains Aug 21 2014
Dealpolitik: Unusual Terms in Salix Inversion Invite an Allergan Bid Aug 21 2014
The Zacks Analyst Blog Highlights: Johnson & Johnson, Tekmira Pharmaceuticals, Gilead Sciences,... Aug 21 2014
[$$] Allergan, Seeking to Fend Off Hostile Bid, Approaches Salix Aug 20 2014
Allergan Talks to Buy Salix in Defense Move Said to Be Dormant Aug 20 2014
Salix Pharmaceuticals Jumps on Takeover Rumours by Allergan Aug 20 2014
Secret Recordings and Other Unusual Claims from the Allergan, Valeant Suits Aug 20 2014
In the Eye of the Beholder: Dueling Descriptions in Allergan, Valeant Suits Aug 20 2014
Some ETFs Salivating for a Salix Takeover Aug 20 2014
Video: Allergan May Seek Salix Deal To Avoid Valeant Aug 19 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide